Z Gastroenterol 2008; 46: 25-28
DOI: 10.1055/s-2007-963490

© Georg Thieme Verlag KG Stuttgart · New York

Implementation of Colorectal Cancer Screening in Finland: Experiences from the First Three Years of a Public Health Programme

N. Malila1 , T. Oivanen2 , M. Hakama1
  • 1Finnish Cancer Registry, Mass Screening Registry, Helsinki, Finland
  • 2Pirkanmaa Cancer Society, Tampere, Finland
Further Information

Publication History

Publication Date:
26 March 2008 (online)


Background and study aims: Colorectal cancer mortality can be reduced by repeated screening, using faecal occult blood testing. This report describes the implementation of service screening in Finland and performance indicators from the first three years. Methods: The programme is based on gradual expansion over six years of implementation. It involves individual-level randomisation into screening or control arms among a target population of men and women aged 60 - 69 years. The effects will be evaluated comparing incidence of and mortality from colorectal cancer in the invited arm with the controls. The screening test is a biannual guaiac-based faecal occult blood test with three test cards for consecutive samples and colonoscopies offered to those with any blood observed. Results: Between September 2004 and December 2006, 52 994 test kits (to 26 247 men and 26 747 women) were sent out in 160 municipalities out of 444. Attendance to screening was 71 % overall, 63 % in men and 78 % in women. People from the youngest age-group (born in 1946) were less compliant than those from the oldest one (born in 1940). Among the screened, 2.1 % were found with blood in the stools, 3 % of men and 1.5 % of women. Cancers and adenomas were detected according to expectations, in 8.6 and 43.2 %, respectively, among those who underwent colonoscopy. Conclusions: The implementation measured with attendance and performance of the test of colorectal cancer screening in Finland has been successful. The programme meets the criteria both for a randomised trial and for a public health programme allowing unbiased data to be collected during the implementation period.


  • 1 Finnish Cancer Registry .Cancer in Finland 2002 and 2003. Helsinki; Cancer Society of Finland 2005
  • 2 Kronborg O, Fenger C, Olsen J. et al . Randomised study of screening for colorectal cancer with faecal-occult-blood test.  Lancet. 1996;  348 1467-1471
  • 3 Hardcastle J D, Chamberlain J O, Robinson M H. et al . Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.  Lancet. 1996;  348 1472-1477
  • 4 Mandel J S, Bond J H, Church T R. et al . Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.  N Engl J Med. 1993;  328 1365-1371
  • 5 Bretthauer M, Gondal G, Larsen K. et al . Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention).  Scand J Gastroenterol. 2002;  37 568-573
  • 6 Atkin W S, Edwards R, Wardle J. et al . Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening.  J Med Screen. 2001;  8 137-144
  • 7 Segnan N, Senore C, Andreoni B. et al . Baseline findings of the Italian multicenter randomized controlled trial of “once-only sigmoidoscopy” - SCORE.  J Natl Cancer Inst. 2002;  94 1763-1772
  • 8 Council Recommendation of 2 December 2003 on cancer screening.  Official Journal of the European Union. 2003;  2003 / 878 /EC 34-38
  • 9 Hakama M, Hoff G, Kronborg O. et al . Screening for colorectal cancer.  Acta Oncol. 2005;  44 425-439
  • 10 Malila N, Hakama M, Pukkala E. A 25-year follow-up of a population screened with faecal occult blood test in Finland.  Acta Oncol. 2007;  In press
  • 11 Malila N, Anttila A, Hakama M. Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004.  J Med Screen. 2005;  12 28-32
  • 12 Towler B P, Irwig L, Glasziou P. et al . Screening for colorectal cancer using the faecal occult blood test, hemoccult.  Cochrane Database Syst Rev. 2000;  CD001216
  • 13 Mandel J S, Church T R, Ederer F. et al . Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.  J Natl Cancer Inst. 1999;  91 434-437
  • 14 Steele R J, Parker R, Patnick J. et al . A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies.  J Med Screen. 2001;  8 197-202
  • 15 Weller D, Alexander F E, Orbell S. et al .Evaluation of the UK Colorectal Cancer Screening Pilot. Edinburgh; University of Edinburgh 2003
  • 16 Hakama M, Pukkala E, Heikkila M. et al . Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study.  BMJ. 1997;  314 864-867

Nea Malila

Finnish Cancer Registry

Liisankatu 21 B

FIN-00170 Helsinki, Finland

Phone: ++ 3 58/9/13 53 31

Fax: ++ 3 58/9/67 31 08

Email: nea.malila@cancer.fi